Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-125494
Filing Date
2024-11-12
Accepted
2024-11-12 16:24:50
Documents
76
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyra-20240930.htm   iXBRL 10-Q 2425197
2 EX-31.1 lyra-ex31_1.htm EX-31.1 16543
3 EX-31.2 lyra-ex31_2.htm EX-31.2 16537
4 EX-32.1 lyra-ex32_1.htm EX-32.1 9112
5 EX-32.2 lyra-ex32_2.htm EX-32.2 9101
  Complete submission text file 0000950170-24-125494.txt   8810447

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT lyra-20240930.xsd EX-101.SCH 1297935
79 EXTRACTED XBRL INSTANCE DOCUMENT lyra-20240930_htm.xml XML 1336101
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Filer) CIK: 0001327273 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39273 | Film No.: 241448684
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)